Liver study tests safety of experimental drugs
NCT ID NCT07546760
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study looks at how the liver affects two experimental drugs, AZD9550 and AZD6234. Researchers will give a single dose to 28 adults with different levels of liver function (normal, moderate, or severe impairment) to see how the drugs move through the body and if they are safe. The goal is to understand dosing needs for people with liver issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGChandler, Arizona, 85225, United States
-
Research Site
RECRUITINGRialto, California, 92377, United States
-
Research Site
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.